NCT06801457View on ClinicalTrials.gov

Adjuvant Cerebroprotection Using Normobaric Hyperoxia in Pre-hospital Patients with Suspected Stroke

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

January 30, 2028

Study Completion Date

January 30, 2028

Conditions
Stroke Acute
Interventions
OTHER

NBO

NBO will be conducted with inhalation of 100% oxygen.

OTHER

Control

Best medical care

Trial Locations (1)

100053

Xuanwu Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

Capital Medical University

OTHER